Laboratory investigation of anaphylaxis: Not as easy as it seems

Anaesthesia

Volumn 70, Issue 1, 2015, Pages 1-5

  Sheldon, J ^a   Philips, B ^a,b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; ATRACURIUM BESILATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORHEXIDINE; CHYMASE; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; PROSTAGLANDIN; PROTEOGLYCAN; ROCURONIUM; SUXAMETHONIUM; TRYPTASE; BIOLOGICAL MARKER;

ANAPHYLAXIS; ANESTHESIA; ANESTHESIST; ANGIONEUROTIC EDEMA; ASTHMA; CAPILLARY LEAK SYNDROME; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMPLEMENT ACTIVATION; CONVALESCENCE; CROSS LINKING; DISEASE SEVERITY; DRUG EXPOSURE; EDITORIAL; ENZYME BLOOD LEVEL; ERYTHEMA; GENDER; HALF LIFE TIME; HEART MASSAGE; HEMODILUTION; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNOLOGIST; LABORATORY TEST; LARYNX EDEMA; MAST CELL; MEDIATOR RELEASE; MEDICAL HISTORY; MULTIPLE TRAUMA; PATHOGENESIS; PRACTICE GUIDELINE; QUALITY CONTROL; RESPIRATORY FAILURE; RESUSCITATION; SECRETORY GRANULE; SMOOTH MUSCLE CONTRACTION; SYSTEMIC ANAPHYLAXIS; THROMBOCYTE ACTIVATION; TIME OF DEATH; URTICARIA; BLOOD; CHEMICALLY INDUCED; ENZYME ASSAY; FEMALE; MALE; PROCEDURES;

ANAPHYLAXIS; ANESTHESIA; BIOLOGICAL MARKERS; CLINICAL ENZYME TESTS; FEMALE; HUMANS; MALE; TRYPTASES;

EID: 84916604190     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12926     Document Type: Editorial

References (22)

1. Mertes P, Alla F, Trechot P, Auroy Y, Jougla E. Anaphylaxis during anesthesia in France: an 8-year national survey. Journal Allergy and Clinical Immunology 2011; 128: 366-73.
2. Krishna M, York M, Chin T, et al. Multicentre retrospective analysis of anaphylaxis during general anaesthesia in the UK: aetiology and diagnostic performance of acute serum tryptase. Clinical and Experimental Immunology 2014; 178: 399-404.
3. Gibb N, Sadleir P, Clarke R, Platt R. Survival from perioperative anaphylaxis in Western Australia 2000-2009. British Journal of Anaesthesia 2013; 111: 589-93.
4. Reitter M, Petitpain N, Latarche C, et al. Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis. Allergy 2014; 69: 954-9.
5. Moore N, Biour M, Paux G, et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985; 2: 1056-8.
6. Cook TM. NAP6 anaphylaxis: what and why? Royal College of Anaesthetists Bulletin 2013; November: 42-3.
7. Florvaag E, Johansson S. The pholcodine story. Immunology and Allergy Clinics of North America 2009; 29: 419-27.
8. Perkvist N, Edston E. Differentail accumulation of pulmonary and caridam mast sell-substes and eosinophils between fatal anaphylazis and asthma death. A post-mortem comparative study. Forensic Science International 2007; 169: 43-9.
9. Patella V, de Crescenzo G, Ciccarelli A, Marino I, Adt M, Marone G. Human heart mast cells: a definitive case of mast cell hetero-geneity. International Archives of Allergy and Immunology 1995; 106: 386-93.
10. Marone G, de Crescenzo G, Adt M, Patella V, Arbustini E, Genovese A. Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 1995; 31: 1-18.
11. Johansson SGO, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813-24.
12. Association of Anaesthetists of Great Britain and Ireland. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009; 64: 199-211.
13. Ewan PW, Dugué P, Mirakian R, Dixon TA, Harper JN, Nasser SM. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clinical and Experimental Allergy 2010; 40: 15-31.
14. National Institute for Health and Care Excellence. Drug allergy: diagnosis and management of drug allergy in adults, children and young people. NICE Clinical Guideline 183. London: NICE, 2014. http://www.nice.org.uk/guidance/cg183/resources/guidance-drug-allergy-diagnosis-and-management-of-drug-allergy-in-adults-children-and-young-people-pdf.
15. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunology and Allergy Clinics of North America 2006; 26: 451-63.
16. Schwartz LB, Irani A-MA, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. Journal of Immunology 1987; 138: 2611-5.
17. Johnson PRA, Ammit AJ, Carlin SM, Armour CL, Caughey GH, Black JL. Mast cell tryptase potentiates histamineinduced contraction in human sensitized bronchus. European Respiratory Journal 1997; 10: 38-43.
18. Thomas VA, Wheeless CJ, Stack MS, Johnson DA. Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption. Biochemistry 1998; 37: 2291-8.
19. Schwartz LB, Metcalfe DD, Miller JS, et al. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. New England Journal of Medicine 1987; 316: 1622-6.
20. Allergy. In: Milford Ward A, Sheldon J, Rowbottom A, Wild GD, Eds. Handbook of Clinical Immunochemistry, 9th edn. Sheffield: PRU Publications, 2007.
21. McLean-Tooke A, Goulding M, Bundell C, White J, Hollingsworth P. Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deaths. Journal of Clinical Pathology 2014; 67: 134-8.
22. Edston E, van Hage-Hamsten M. Mast cell tryptase and haemolysis after trauma. Forensic Science International 2003; 131: 8-13.